Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

997
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
997
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

125
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
125
Liver Physiology01:30

Liver Physiology

415
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of  70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
415
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

426
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
426
Liver Regeneration01:24

Liver Regeneration

3.2K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.2K
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

71
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
71

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Liver Aging Index: A Noninvasive Score for Liver Biological Aging and Liver-Related Outcomes in Multicohorts.

Aging cell·2026
Same author

Microenvironment T-Type calcium channels regulate neuronal and glial processes in tumor cells to promote glioblastoma growth.

Neuro-oncology·2026
Same author

The Natural History and Individualized Prediction of Liver Stiffness-Based Fibrosis Risk in MASLD.

Clinical and molecular hepatology·2026
Same author

Underutilization of PETH testing among patients with MASLD - retrospective, single-center evaluation of the frequency and results of phosphatidylethanol testing among patients diagnosed with metabolic dysfunction-associated liver disease.

Journal of addictive diseases·2026
Same author

Pressure injury severity and trajectory: A 5-year cohort study in an Australian health district.

Journal of tissue viability·2026
Same author

Quality Assessment of Health Information on Alcohol-Associated Liver Disease on TikTok, United States, 2024.

Public health reports (Washington, D.C. : 1974)·2026

Related Experiment Video

Updated: Jun 2, 2025

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

767

Metabolic Dysfunction-Associated Steatotic Liver Disease.

Sajjadh M J Ali1, Michelle Lai1

  • 1Department of Medicine, Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts (S.M.J.A., M.L.).

Annals of Internal Medicine
|January 13, 2025
PubMed
Summary

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a common liver condition. Early diagnosis and lifestyle changes are key to managing MASLD and preventing severe outcomes like liver cancer.

More Related Videos

A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
08:35

A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium

Published on: May 18, 2021

6.2K
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

15.9K

Related Experiment Videos

Last Updated: Jun 2, 2025

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

767
A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
08:35

A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium

Published on: May 18, 2021

6.2K
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

15.9K

Area of Science:

  • Hepatology
  • Metabolic Disorders
  • Gastroenterology

Background:

  • Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent chronic liver disease in the U.S.
  • MASLD is characterized by liver fat accumulation and is potentially reversible.
  • Key risk factors include obesity, type 2 diabetes mellitus, and metabolic syndrome.

Purpose of the Study:

  • To summarize the current understanding of MASLD and its more severe form, MASH.
  • To highlight the importance of early diagnosis and intervention.
  • To outline management strategies and therapeutic options.

Main Methods:

  • Review of existing literature on MASLD and MASH.
  • Analysis of risk factors and disease progression.
  • Summary of current and potential treatment modalities.

Main Results:

  • MASLD affects a significant portion of the population, linked to metabolic risk factors.
  • Metabolic dysfunction-associated steatohepatitis (MASH) increases the risk of cirrhosis, liver decompensation, and hepatocellular carcinoma.
  • Lifestyle modifications (diet, exercise, weight loss) are fundamental to management.

Conclusions:

  • Early detection and intervention are crucial for preventing severe liver disease progression.
  • While lifestyle changes are primary, pharmacotherapies and bariatric surgery play roles in managing metabolic risk factors and MASLD/MASH.
  • Further research into targeted treatments for MASH is ongoing.